Ictal and Interictal Inflammatory Markers in Migraine

Completed · Phase 4 · Has a placebo group

Conditions studied: Migraine

In brief

The purpose of this study is to evaluate blood levels of several proteins that may be altered in the inflammation associated with migraine headaches. These blood levels will be evaluated in individuals during an acute migraine attack and compared to their levels when pain free. The investigators study hypothesis is that the pro inflammatory proteins in the blood will be greater than the levels of these proteins when evaluated during a pain free period.

Key facts

Study ID

NCT01138150

Run by

Johns Hopkins University

People needed

36

Starts

2009-09-01

Expected to finish

2013-06-01

Last updated by the study team

2016-10-06

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age greater than 18 years of age, migraine

You may not qualify if…

• Pregnant or breast-feeding women, presence of cardiovascular or cerebrovascular disorders as well as any known inflammatory, infectious, metabolic, thyroid, renal, cardiovascular or gastrointestinal diseases

Where it is running

• The Johns Hopkins Bayview Headache Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.